Research on respiratory illness requires continuous testing of large patient groups. Integrity of data requires reliable monitoring methods. KAMU® provides a solution that works through the whole chain of finding, recruiting, monitoring, treating and retaining patients during the study. Meticulous tracking and reliable adherence during the study are especially important for approval of the new expensive biological medicines.
KAMU Asthma® is a new way of thinking respiratory care. It enables the patient to take a spirometry test at home and track their symptoms and adherence to medication with quick, easy-to-use and comparable questionnaires. Combining data about external triggers to this patient-provided information, KAMU creates reports that help both the patient and the researcher understand the condition better.